NuvalentNUVL
Price
$ 86.25
Market Capitalization
$ 5.59 B
Shares Outstading
64.798 M
Change
$ 1.29
Percentage Change
1.52 %
Country
United States 🇺🇸
Industry
Biotechnology
Healthcare
Exchange
NASDAQ Global Select
IPO
2021-07-29
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and rem
Market Capitalization of Nuvalent ( NUVL)
Market Capitalization : $ 5.59 Billion
Nuvalent has Market Capitalization of $ 5.59 Billion .The current price of Nuvalent is $86.25 (1.52 %). Market capitalization, commonly referred to as market cap, represents the total market value of a publicly traded company's outstanding shares and serves as a widely used metric for assessing a company's overall worth.
Market Capitalization of Nuvalent from 2021 to 2024
Year on Year Market Capitalization of Nuvalent
| Year | Market Capitalization | Change % |
|---|---|---|
| 06-01-2024 | $ 4.53 B | 177.13% |
| 03-01-2023 | $ 1.64 B | 151.01% |
| 31-01-2022 | $ 651.40 M | -23.77% |
| 30-07-2021 | $ 854.50 M |
Market Cap of Magnificent 7
Stock Ticker | Market Cap | Price | Change | Price(30 Days) | Country |
|---|---|---|---|---|---|
$ 3.357 T | $ 220.82 -0.70% | $ -1.56 | United States🇺🇸 | ||
$ 2.986 T | $ 401.7 -1.64% | $ -6.69 | United States🇺🇸 | ||
$ 2.522 T | $ 102.83 -4.09% | $ -4.38 | United States🇺🇸 | ||
$ 1.864 T | $ 152.13 -4.08% | $ -6.47 | United States🇺🇸 | ||
$ 1.799 T | $ 171.39 -3.65% | $ -6.5 | United States🇺🇸 | ||
$ 1.776 T | $ 7.3453 0.00% | $ 0 | Saudi Arabia🇸🇦 | ||
$ 1.266 T | $ 500.27 -3.21% | $ -16.59 | United States🇺🇸 |
